البحث عن طبيب

Melissa R. Snyder, Ph.D.

  1. Chemist

المنشورات

  1. Ender E, Joshi A, Snyder M, Kumar S, Hentz R, Creo A. Seroconversion following PPSV23 vaccination in children with type 1 diabetes mellitus. Vaccine. 2024 Dec 11; 45:126592 [Epub ahead of print]
    View PubMed
  2. Suttichaimongkol T, Coelho-Prabhu N, Bruining DH, Tariq R, Snyder MR, Loftus EV Jr. Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center. Inflamm Bowel Dis. 2024 Dec 5; 30 (12):2347-2355
    View PubMed
  3. Mohammed Ismail W, Fernandez J, Binder M, Lasho TL, Kim M, Geyer S, Mazzone A, Finke CM, Mangaonkar AA, Lee JH, Wang L, Kim KH, Simon VA, Rakhshan Rohakthar F, Munankarmy A, Byeon SK, Schwager SM, Harington JJ, Snyder MR, Robertson KD, Pandey A, Wieben ED, Chia N, Gaspar-Maia A, Patnaik MM. Single cell multiomics reveal divergent effects of DNMT3A and TET2 mutant clonal hematopoiesis in inflammatory response. Blood Adv. 2024 Dec 4 Epub 2024 Dec 04
    View PubMed
  4. Saadalla A, Chen D, Stuart M, Pruthi R, Heikal N, Snyder M, Ashrani A, Seheult J. The lupus anticoagulant titer is associated with elevated antiphosphatidylserine/prothrombin immunoglobulin-M isotype antibody levels. Int J Lab Hematol. 2024 Aug; 46 (4):695-704 Epub 2024 Feb 21
    View PubMed
  5. Karsten C, Grannas K, Bergman O, Moverare R, Roforth M, Willrich MAV, Snyder MR, Yang YK. Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation. AAPS J. 2024 Jul 24; 26 (5):86 Epub 2024 July 24
    View PubMed
  6. Ladwig PM, Rivard AL, Barbeln A, Maus A, Murray DL, Snyder MR, Willrich MAV. Infliximab Therapeutic monitoring by tryptic peptide LC-MS/MS method improvements lead to improved accuracy with decreased imprecision and turnaround time. J Mass Spectrom Adv Clin Lab. 2024 Apr; 32:24-30 Epub 2024 Feb 03
    View PubMed
  7. Kemp J, Ladwig PM, Snyder MR. Alpha-1-Antitrypsin (A1AT) Proteotyping by LC-MS/MS. Methods Mol Biol. 2024; 2750:95-106
    View PubMed
  8. Ganesh R, Yadav S, Hurt RT, Mueller MR, Aakre CA, Gilman EA, Grach SL, Overgaard J, Snyder MR, Collins NM, Croghan IT, Badley AD, Razonable RR, Salonen BR. Pro Inflammatory Cytokines Profiles of Patients With Long COVID Differ Between Variant Epochs. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241254751
    View PubMed
  9. Tebo AE, Peterson LK, Snyder MR, Lebiedz-Odrobina D. Clinical Significance of Anti-U1 Ribonucleoprotein Antibody Is Analyte Dependent: Implications for Laboratory Reporting, Interpretation, and Interassay Correlations. Arch Pathol Lab Med. 2023 Dec 1; 147 (12):1461-1465
    View PubMed
  10. Galior KD, Ladwig PM, Snyder MR, Algeciras-Schimnich A, Bornhorst JA, Block DR, Baumann NA, Willrich MAV. Lack of observed interference by therapeutic monoclonal antibodies in select commonly utilized immunoassays. Clin Biochem. 2023 Nov; 121-122:110685 Epub 2023 Nov 14
    View PubMed
  11. Al-Bawardy B, Jenkins SM, Snyder MR, Frinack JL, Ladwig PM, Loftus EV Jr, Willrich MAV. Outcomes of Infliximab-Treated inflammatory bowel disease patients undergoing therapeutic drug monitoring with two different assays. Clin Biochem. 2023 Sep; 119:110618 Epub 2023 July 26
    View PubMed
  12. Rozenova K, Willrich M, Snyder M, Dasari S, Kourelis T, Rajkumar SV, Kumar S, Dispenzieri A, Murray DL. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance. J Appl Lab Med. 2023 Jul 5; 8 (4):742-750
    View PubMed
  13. Pham MM, Orsolini G, Crowson CS, Snyder MR, Pruthi RK, Moder KG. Is There Clinically Relevant Plasma Interference with ELISA Detection of APS Antibodies? Reproducibility of Real-World Paired Serum and Plasma Testing. Thromb Haemost 2022 Nov; 122 (11):1948-1950 Epub 2022 June 13
    View PubMed
  14. Pham M, Orsolini G, Crowson C, Snyder M, Pruthi R, Moder K. Anti-phosphatidylserine prothrombin antibodies as a predictor of the lupus anticoagulant in an all-comer population. J Thromb Haemost. 2022 Sep; 20 (9):2070-2074 Epub 2022 July 11
    View PubMed
  15. Ashrafzadeh-Kian S, Campbell MR, Jara Aguirre JC, Walsh J, Kumanovics A, Jenkinson G, Rinaldo P, Snyder MR, Algeciras-Schimnich A. Role of immune mediators in predicting hospitalization of SARS-CoV-2 positive patients. Cytokine. 2022 Feb; 150:155790. Epub 2021 Dec 25.
    View PubMed
  16. Dasari S, Kohlhagen MC, Dispenzieri A, Willrich MAV, Snyder MR, Kourelis TV, Lust JA, Mills JR, Kyle RA, Murray DL. Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases. Mayo Clin Proc. 2022 Feb; 97 (2):294-307 Epub 2021 Dec 07
    View PubMed
  17. Horton RK, Hagen CE, Snyder MR. Pediatric Celiac Disease: A Review of Diagnostic Testing and Guideline Recommendations. J Appl Lab Med. 2022 Jan 5; 7 (1):294-304
    View PubMed
  18. Larkey NE, Denome AM, Snyder MR. Correlation of ANA Characteristics with pANCA IFA Interference. J Appl Lab Med. 2022 Jan 5; 7 (1):75-80
    View PubMed
  19. Kulasingam V, Booth RA, Peterson LK, Snyder MR. The Journal of Applied Laboratory Medicine Special Issue on Autoimmune Diagnostics. J Appl Lab Med. 2022 Jan 5; 7 (1):1-2
    View PubMed
  20. Fatica EM, Martinez M, Ladwig PM, Murray JD, Kohlhagen MC, Kyle RA, Kourelis T, Lust JA, Snyder MR, Dispenzieri A, Murray DL, Willrich MAV. MALDI-TOF mass spectrometry can distinguish immunofixation bands of the same isotype as monoclonal or biclonal proteins. Clin Biochem. 2021 Nov; 97:67-73 Epub 2021 Aug 09
    View PubMed
  21. Ivy MI, Sharma K, Greenwood-Quaintance KE, Tande AJ, Osmon DR, Berbari EF, Mandrekar J, Beauchamp CP, Hanssen AD, Abdel MP, Lewallen DG, Perry K, Block DR, Snyder MR, Patel R. Synovial fluid alpha defensin has comparable accuracy to synovial fluid white blood cell count and polymorphonuclear percentage for periprosthetic joint infection diagnosis. Bone Joint J. 2021 Jun; 103-B (6):1119-1126
    View PubMed
  22. Park MA, Jenkins SM, Smith CY, Pyle RC, Sacco KA, Ryu E, Hagan JB, Joshi AY, Snyder MR, Abraham RS. Pneumococcal serotype-specific cut-offs based on antibody responses to pneumococcal polysaccharide vaccination in healthy adults. Vaccine. 2021 May 18; 39 (21):2850-2856 Epub 2021 Apr 22
    View PubMed
  23. Knight V, Askar MZ, Ntrivalas E, Nandiwada SL, Peterson LK, Tebo AE, Kadkhoda K, Schmitz JL, Naides SJ, Snyder MR, Sadighi Akha AA. Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI). J Immunol Methods. 2021 May; 492:112994 Epub 2021 Feb 21
    View PubMed
  24. Kunchok A, Flanagan EP, Snyder M, Saadeh R, Chen JJ, Weinshenker BG, McKeon A, Pittock SJ. Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD. Mult Scler. 2021 Apr; 27 (4):630-635 Epub 2020 July 07
    View PubMed
  25. Murray JD, Willrich MA, Krowka MJ, Bobr A, Murray DL, Halling KC, Graham RP, Snyder MR. Liquid Chromatography-Tandem Mass Spectrometry-Based alpha1-Antitrypsin (AAT) Testing. Am J Clin Pathol. 2021 Mar 15; 155 (4):547-552
    View PubMed
  26. Sadighi Akha AA, Tschumper RC, Mills JR, Isham CR, Witty EE, Viswanatha DS, Dasari S, Snyder MR, Murray DL, Katzmann JA, Jelinek DF, Willrich MAV. A rare case of selective Igkappa chain deficiency: Biologic and clinical implications. J Allergy Clin Immunol 2020 Nov; 146 (5):1208-1210.e6 Epub 2020 Apr 08
    View PubMed
  27. David M, Murray DL, Dispenzieri A, Kumar S, Gill H, Vachon C, Snyder M, Willrich M. Free Light Chain Assay Drift: Potential for Misdiagnosis? J Appl Lab Med 2020 Nov 1; 5 (6):1411-1413
    View PubMed
  28. Isikwei E, Shrestha P, Snyder MR, Kabat BF, Rabe KG, Slager SL, Parikh SA, Joshi AY. Risk factors for hypogammaglobulinemia in chronic lymphocytic leukemia patients treated with anti-CD20 monoclonal antibody-based therapies Journal of Hematopathology. 2020.
  29. Sidana S, Murray DL, Dasari S, Go RS, Muchtar E, Willrich MA, Snyder M, Kohlhagen M, Lust JA, Kourelis TV, Kumar SK, Dispenzieri A, Gertz MA. Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease. Am J Hematol 2020 Sep; 95 (9):E222-E225 Epub 2020 June 12
    View PubMed
  30. Choung RS, Mills JR, Snyder MR, Murray JA, Gandhi MJ. Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 ~ DQB1) typing in a large cohort of adults with suspected celiac disease. Hum Immunol. 2020 Feb - Mar; 81 (2-3):59-64 Epub 2020 Jan 28
    View PubMed
  31. Thompson GE, Fussner LA, Hummel AM, Schroeder DR, Silva F, Snyder MR, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Specks U. Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis. Front Immunol. 2020; 11:2053 Epub 2020 Sept 03
    View PubMed
  32. Turner KA, Eckelkamp LL, Kalass SJ, Martinez MA, Brewer HR, Hoyne JB, Snyder MR, Murray DL, Willrich MAV. Correlation Between Kappa Prozone Effect and IgA Kappa M Proteins in Serum Free Light-Chain Assay. Clin Chem 2019 Oct; 65 (10):1327-1329 Epub 2019 Aug 06
    View PubMed
  33. Sepiashvili L, Kohlhagen MC, Snyder MR, Willrich MAV, Mills JR, Dispenzieri A, Murray DL. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry. Clin Chem. 2019 Aug; 65 (8):1015-1022 Epub 2019 June 06
    View PubMed
  34. Bledsoe AC, King KS, Larson JJ, Snyder M, Absah I, Choung RS, Murray JA. Micronutrient Deficiencies Are Common in Contemporary Celiac Disease Despite Lack of Overt Malabsorption Symptoms. Mayo Clin Proc. 2019 Jul; 94 (7):1253-1260
    View PubMed
  35. Nasr SH, Dasari S, Lieske JC, Benson LM, Vanderboom PM, Holtz-Heppelmann CJ, Giesen CD, Snyder MR, Erickson SB, Fervenza FC, Leung N, Kurtin PJ, Alexander MP. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients. Kidney Int. 2019 May; 95 (5):1269-1272 Epub 2019 Mar 01
    View PubMed
  36. Lazar-Molnar E, Snyder M. The Role of Human Leukocyte Antigen in Celiac Disease Diagnostics. Clin Lab Med. 2018 Dec; 38 (4):655-668 Epub 2018 Oct 05
    View PubMed
  37. Willrich MAV, Andreguetto BD, Sridharan M, Fervenza FC, Tostrud LJ, Ladwig PM, Rivard AM, Hetrick MD, Olson RN, Bryant SC, Snyder MR, Murray DL. The impact of eculizumab on routine complement assays. J Immunol Methods. 2018 Sep; 460:63-71 Epub 2018 June 20
    View PubMed
  38. Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, Roforth MM, Mandrekar J, Mauermann ML, Taylor BV, Dyck PJB, Windebank AJ, Klein CJ. Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM. Muscle Nerve. 2018 Jun; 57 (6):1000-1005 Epub 2018 Jan 26
    View PubMed
  39. Willrich MAV, Lazar-Molnar E, Snyder MR, Delgado JC. Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to Infliximab. J Appl Lab Med. 2018 May 1; 2 (6):893-903
    View PubMed
  40. Cornec D, Kabat BF, Mills JR, Cheu M, Hummel AM, Schroeder DR, Cascino MD, Brunetta P, Murray DL, Snyder MR, Fervenza F, Hoffman GS, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Barnidge DR, Specks U. Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis. Rheumatology (Oxford). 2018 Apr 1; 57 (4):639-650
    View PubMed
  41. Wongjarupong N, Negron-Ocasio GM, Chaiteerakij R, Addissie BD, Mohamed EA, Mara KC, Harmsen WS, Theobald JP, Peters BE, Balsanek JG, Ward MM, Giama NH, Venkatesh SK, Harnois DM, Charlton MR, Yamada H, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol. 2018 Mar 28; 24 (12):1321-1331
    View PubMed
  42. Fang H, King KS, Larson JJ, Snyder MR, Wu TT, Gandhi MJ, Murray JA. Undetectable negative tissue transglutaminase IgA antibodies predict mucosal healing in treated coeliac disease patients. Aliment Pharmacol Ther. 2017 Oct; 46 (7):681-687 Epub 2017 Aug 07
    View PubMed
  43. Absah I, Rishi AR, Gebrail R, Snyder MR, Murray JA. Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative. J Pediatr Gastroenterol Nutr. 2017 May; 64 (5):726-729
    View PubMed
  44. Cotten SW, Snyder MR. Antinuclear Antibody Screening: A Delicate Balance for Clinical Laboratories. J Appl Lab Med. 2017 May 1; 1 (6):609-612
    View PubMed
  45. Kohlhagen MC, Barnidge DR, Mills JR, Stoner J, Gurtner KM, Liptac AM, Lofgren DI, Vanderboom PM, Dispenzieri A, Katzmann JA, Willrich MA, Snyder MR, Murray DL. Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry. Clin Chem. 2016 Oct; 62 (10):1345-52 Epub 2016 Aug 11
    View PubMed
  46. Fussner LA, Hummel AM, Schroeder DR, Silva F, Cartin-Ceba R, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, William St Clair E, Tchao NK, Stone JH, Specks U, Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group. Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3. Arthritis Rheumatol. 2016 Jul; 68 (7):1700-10
    View PubMed
  47. Deng X, Peters B, Ettore MW, Ashworth J, Brunelle LA, Crowson CS, Moder KG, Snyder MR. Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort. J Appl Lab Med. 2016 Jul 1; 1 (1):36-46
    View PubMed
  48. Mills JR, Cornec D, Dasari S, Ladwig PM, Hummel AM, Cheu M, Murray DL, Willrich MA, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Specks U, Barnidge DR. Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis. Anal Chem. 2016 Jun 21; 88(12):6317-25. Epub 2016 Jun 03.
    View PubMed
  49. Willrich MA, Ladwig PM, Andreguetto BD, Barnidge DR, Murray DL, Katzmann JA, Snyder MR. Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation. Clin Chem Lab Med. 2016 Jun 01; 54(6):1085-93.
    View PubMed
  50. Choung RS, Marietta EV, Van Dyke CT, Brantner TL, Rajasekaran J, Pasricha PJ, Wang T, Bei K, Krishna K, Krishnamurthy HK, Snyder MR, Jayaraman V, Murray JA. Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide Microarrays. PLoS One. 2016; 11(1):e0147777. Epub 2016 Jan 29.
    View PubMed
  51. Snyder MR, Murray JA. Celiac disease: advances in diagnosis. Expert Rev Clin Immunol. 2016; 12: (4)449-63.
    View PubMed
  52. Graham RP, Dina MA, Howe SC, Butz ML, Willkomm KS, Murray DL, Snyder MR, Rumilla KM, Halling KC, Highsmith WE Jr. SERPINA1 Full-Gene Sequencing Identifies Rare Mutations Not Detected in Targeted Mutation Analysis. J Mol Diagn. 2015 Nov; 17 (6):689-94 Epub 2015 Aug 28
    View PubMed
  53. Willrich MA, Murray DL, Barnidge DR, Ladwig PM, Snyder MR. Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC-MS/MS. Int Immunopharmacol. 2015 Sep; 28(1):513-20. Epub 2015 Jul 25.
    View PubMed
  54. Donato LJ, Karras RM, Katzmann JA, Murray DL, Snyder MR. Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles. Respir Res. 2015 Aug 05; 16(1):96.
    View PubMed
  55. Chaiteerakij R, Zhang X, Addissie BD, Mohamed EA, Harmsen WS, Theobald PJ, Peters BE, Balsanek JG, Ward MM, Giama NH, Moser CD, Oseini AM, Umeda N, Venkatesh S, Harnois DM, Charlton MR, Yamada H, Satomura S, Algeciras-Schimnich A, Snyder MR, Therneau TM, Roberts LR. Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2015 May; 21 (5):599-606
    View PubMed
  56. Willrich MA, Murray DL, Snyder MR. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases. Transl Res. 2015 Feb; 165 (2):270-82 Epub 2014 Sept 22
    View PubMed
  57. Katzmann JA, Willrich MA, Kohlhagen MC, Kyle RA, Murray DL, Snyder MR, Rajkumar SV, Dispenzieri A. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays. Clin Chem. 2015 Feb; 61(2):360-7. Epub 2014 Dec 01.
    View PubMed
  58. Barnidge DR, Dasari S, Ramirez-Alvarado M, Fontan A, Willrich MA, Tschumper RC, Jelinek DF, Snyder MR, Dispenzieri A, Katzmann JA, Murray DL. Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry. J Proteome Res. 2014 Nov 7; 13(11):5198-205. Epub 2014 Aug 26.
    View PubMed
  59. Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, de Groot P, Lakos G, Lambert M, Meroni P, Ortel TL, Petri M, Rahman A, Roubey R, Sciascia S, Snyder M, Tebo AE, Tincani A, Willis R. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev. 2014 Sep; 13 (9):917-30 Epub 2014 May 10
    View PubMed
  60. Ladwig PM, Barnidge DR, Snyder MR, Katzmann JA, Murray DL. Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography--tandem mass spectrometry. Clin Chem. 2014 Aug; 60(8):1080-8. Epub 2014 May 05.
    View PubMed
  61. Barnidge DR, Tschumper RC, Theis JD, Snyder MR, Jelinek DF, Katzmann JA, Dispenzieri A, Murray DL. Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MS. J Proteome Res. 2014 Apr 4; 13 (4):1905-10 Epub 2014 Mar 05
    View PubMed
  62. Barnidge DR, Dasari S, Botz CM, Murray DH, Snyder MR, Katzmann JA, Dispenzieri A, Murray DL. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy. J Proteome Res. 2014 Mar 7; 13 (3):1419-27 Epub 2014 Feb 11
    View PubMed
  63. Caraballo JN, Snyder MR, Johnston PB, O Neill BP, Raja H, Balsanek JG, Peters BE, Pulido JS. Vitreoretinal lymphoma versus uveitis: cytokine profile and correlations. Ocul Immunol Inflamm. 2014 Feb; 22(1):34-41.
    View PubMed
  64. Crow SS, Oliver WC Jr, Kiefer JA, Snyder MR, Dearani JA, Li Z, Burkhart HM. Dexamethasone levels predict cortisol response after infant cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2014 Jan; 147 (1):475-81 Epub 2013 Nov 08
    View PubMed
  65. Raja H, Snyder MR, Johnston PB, O'Neill BP, Caraballo JN, Balsanek JG, Peters BE, Decker PA, Pulido JS. Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma. PLoS One. 2013; 8 (6):e65627 Epub 2013 June 04
    View PubMed
  66. Murray DL, Seningen JL, Dispenzieri A, Snyder MR, Kyle RA, Rajkumar SV, Katzmann JA. Laboratory persistence and clinical progression of small monoclonal abnormalities. Am J Clin Pathol. 2012 Oct; 138 (4):609-13
    View PubMed
  67. Donato LJ, Jenkins SM, Smith C, Katzmann JA, Snyder MR. Reference and interpretive ranges for a(1)-antitrypsin quantitation by phenotype in adult and pediatric populations. Am J Clin Pathol. 2012 Sep; 138(3):398-405.
    View PubMed
  68. Block DR, Jenkins SM, Dalenberg DA, Balsanek JG, Snyder MR, Saenger AK. Analytical and clinical comparison of anti-CCP assays with rheumatoid factor for the diagnosis of rheumatoid arthritis. Clin Chim Acta. 2012 Jun 14; 413 (11-12):1015-7 Epub 2012 Feb 14
    View PubMed
  69. Katzmann JA, Snyder MR, Rajkumar SV, Kyle RA, Therneau TM, Benson JT, Dispenzieri A. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem. 2011 Dec; 57 (12):1687-92 Epub 2011 Oct 06
    View PubMed
  70. Chen Y, Snyder MR, Zhu Y, Tostrud LJ, Benson LM, Katzmann JA, Bergen HR 3rd. Simultaneous phenotyping and quantification of alpha-1-antitrypsin by liquid chromatography-tandem mass spectrometry. Clin Chem. 2011 Aug; 57 (8):1161-8 Epub 2011 June 02
    View PubMed
  71. Joshi AY, Abraham RS, Snyder MR, Boyce TG. Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency? Vaccine. 2011 Jul 12; 29 (31):5040-6 Epub 2011 May 17
    View PubMed
  72. Ringenbach MR, Banta E, Snyder MR, Craig TJ, Ishmael FT. A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype. Allergy Asthma Clin Immunol. 2011; 7(1):18. Epub 2011 Nov 13.
    View PubMed
  73. Rashtak S, Snyder MR, Pittock SJ, Wu TT, Gandhi MJ, Murray JA. Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol. 2011 Jan; 230 (1-2):130-4 Epub 2010 Nov 06
    View PubMed
  74. Kumar S, Zhang L, Dispenzieri A, Van Wier S, Katzmann JA, Snyder M, Blood E, DeGoey R, Henderson K, Kyle RA, Bradwell AR, Greipp PR, Rajkumar SV, Fonseca R. Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma. Leukemia. 2010 Aug; 24 (8):1498-505 Epub 2010 June 03
    View PubMed
  75. Weingarten TN, Whalen FX, Warner DO, Gajic O, Schears GJ, Snyder MR, Schroeder DR, Sprung J. Comparison of two ventilatory strategies in elderly patients undergoing major abdominal surgery. Br J Anaesth. 2010 Jan; 104 (1):16-22
    View PubMed
  76. Liang KP, Kremers HM, Crowson CS, Snyder MR, Therneau TM, Roger VL, Gabriel SE. Autoantibodies and the risk of cardiovascular events. J Rheumatol. 2009 Nov; 36(11):2462-9. Epub 2009 Oct 15.
    View PubMed
  77. Murray DL, Ryu E, Snyder MR, Katzmann JA. Quantitation of serum monoclonal proteins: relationship between agarose gel electrophoresis and immunonephelometry. Clin Chem. 2009 Aug; 55 (8):1523-9 Epub 2009 June 11
    View PubMed
  78. Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, Rajkumar SV, Dispenzieri A. Screening panels for detection of monoclonal gammopathies. Clin Chem. 2009 Aug; 55 (8):1517-22 Epub 2009 June 11
    View PubMed
  79. Dispenzieri A, Zhang L, Katzmann JA, Snyder M, Blood E, Degoey R, Henderson K, Kyle RA, Oken MM, Bradwell AR, Greipp PR. Appraisal of immunoglobulin free light chain as a marker of response. Blood. 2008 May 15; 111 (10):4908-15 Epub 2008 Mar 25
    View PubMed
  80. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ. Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology. 2007 Dec; 114 (12):2179-82
    View PubMed
  81. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 2007 May; 114 (5):855-9
    View PubMed
  82. Snyder MR, Katzmann JA, Butz ML, Wiley C, Yang P, Dawson DB, Halling KC, Highsmith WE, Highsmith WE, Thibodeau SN. Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping. Clin Chem. 2006 Dec; 52 (12):2236-42 Epub 2006 Oct 19
    View PubMed
  83. Katzmann JA, Dispenzieri A, Kyle RA, Snyder MR, Plevak MF, Larson DR, Abraham RS, Lust JA, Melton LJ 3rd, Rajkumar SV. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc. 2006 Dec; 81 (12):1575-8
    View PubMed
  84. Bakri SJ, Snyder MR, Pulido JS, McCannel CA, Weiss WT, Singh RJ. Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing. Retina. 2006 May-Jun; 26 (5):519-22
    View PubMed
  85. Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J Immunol. 2004 Sep 15; 173 (6):3725-31
    View PubMed
  86. Snyder MR, Weyand CM, Goronzy JJ. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol. 2004 Jan; 25 (1):25-32
    View PubMed
  87. Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J Exp Med. 2003 Feb 17; 197 (4):437-49
    View PubMed
  88. Snyder MR, Muegge LO, Offord C, O'Fallon WM, Bajzer Z, Weyand CM, Goronzy JJ. Formation of the killer Ig-like receptor repertoire on CD4+CD28null T cells. J Immunol. 2002 Apr 15; 168 (8):3839-46
    View PubMed
  89. Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol. 2000 Jul 15; 165 (2):1138-45
    View PubMed
  90. Eblen ST, Fautsch MP, Burnette RJ, Snyder MR, Leof EB. Dissociation of p34cdc2 complex formation from phosphorylation and histone H1 kinase activity. Can Res. 1995; 55:1994-2000.